UnknownNot Applicable

Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

100 participantsStarted 2022-07-11

Plain-language summary

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament. This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All patients older than 18 years, with solid cancer or hematological malignancy receiving anticancer treatment in the outpatient medical department of Alpes Leman Hospital and having a central venous catheter been placed between the 11th of July 2022, and the 1st of January 2023.

What they're measuring

Incidence rate and density of central venous catheter-related complications (infections, thromboses, extravasation)

Timeframe: 6 months

Trial details

NCT IDNCT05455866

SponsorCentre Hospitalier Alpes Leman

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01

Contact for this trial

Florence OBERKAMPF

+33 4 50 82 22 72 foberkampf@ch-alpes-leman.fr

View on ClinicalTrials.gov More Central Venous Catheter Thrombosis trials